I agree that this site is using cookies. You can find further informations here.
X
Cappello, Maria
358  results:
OpenAccess-fulltext X
Search for persons X
?
1

Genetic screening for hereditary transthyretin amyloidosis ..:

Di Stefano, Vincenzo ; Lupica, Antonino ; Alonge, Paolo...
info:eu-repo/semantics/altIdentifier/pmid/37725003.  , 2024
Link: https://hdl.handle.net/1..
 
?
2

SARS-CoV-2 infection in patients with inflammatory bowel di..:

Bezzio, Cristina ; Vernero, Marta ; Costa, Stefania...
info:eu-repo/semantics/altIdentifier/pmid/37407913.  , 2023
Link: https://hdl.handle.net/2..
 
?
3

SARS-CoV-2 infection in patients with inflammatory bowel di..:

Bezzio, Cristina ; Vernero, Marta ; Costa, Stefania...
info:eu-repo/semantics/altIdentifier/pmid/37407913.  , 2023
Link: https://hdl.handle.net/1..
 
?
4

SARS-CoV-2 infection in patients with inflammatory bowel di..:

Bezzio, Cristina ; Vernero, Marta ; Costa, Stefania...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10324268/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
5

SARS-CoV-2 infection in patients with inflammatory bowel di..:

Bezzio, Cristina ; Vernero, Marta ; Costa, Stefania...
info:eu-repo/semantics/altIdentifier/pmid/37407913.  , 2023
Link: https://hdl.handle.net/1..
 
?
6

SARS-CoV-2 infection in patients with inflammatory bowel di..:

Bezzio, Cristina ; Vernero, Marta ; Costa, Stefania...
info:eu-repo/semantics/altIdentifier/pmid/37407913.  , 2023
Link: https://hdl.handle.net/2..
 
?
7

Management of Non-response and Loss of Response to Anti-tum..:

Marsal, Jan ; Barreiro-de Acosta, M ; Blumenstein, Irina...
info:eu-repo/semantics/altIdentifier/doi/10.3389/fmed.2022.897936.  , 2022
Link: https://hal.science/hal-..
 
?
8

Management of Non-response and Loss of Response to Anti-tum..:

Marsal, Jan ; Barreiro-de Acosta, M ; Blumenstein, Irina...
info:eu-repo/semantics/altIdentifier/doi/10.3389/fmed.2022.897936.  , 2022
Link: https://hal.science/hal-..
 
?
9

Management of Non-response and Loss of Response to Anti-tum..:

Marsal, Jan ; Barreiro-de Acosta, M ; Blumenstein, Irina...
info:eu-repo/semantics/altIdentifier/doi/10.3389/fmed.2022.897936.  , 2022
Link: https://hal.science/hal-..
 
?
10

Effectiveness and safety of vedolizumab in a matched cohort..:

Pugliese, Daniela ; Privitera, Giuseppe ; Crispino, Federica...
info:eu-repo/semantics/altIdentifier/pmid/35876062.  , 2022
Link: https://hdl.handle.net/2..
 
?
11

An Objective Comparison of Vedolizumab and Ustekinumab Effe..:

Onali, Sara ; Pugliese, Daniela ; Caprioli, Flavio Andrea...
info:eu-repo/semantics/altIdentifier/pmid/35467558.  , 2022
Link: https://hdl.handle.net/2..
 
?
12

Management of Non-response and Loss of Response to Anti-tum..:

Marsal, Jan ; Barreiro-de Acosta, Manuel ; Blumenstein, Irina...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9241563/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
13

Effectiveness and safety of vedolizumab in a matched cohort..:

Pugliese, Daniela ; Privitera, Giuseppe ; Crispino, Federica...
info:eu-repo/semantics/altIdentifier/pmid/35876062.  , 2022
Link: https://hdl.handle.net/1..
 
?
14

Ultrasonography Tight Control and Monitoring in Crohn's Dis..:

Calabrese, Emma ; Rispo, Antonio ; Zorzi, Francesca...
info:eu-repo/semantics/altIdentifier/pmid/33775896.  , 2021
Link: http://hdl.handle.net/24..
 
?
15

Ustekinumab in Crohn's disease: Real‐world outcomes from th..:

Viola, Anna ; Muscianisi, Marco ; Macaluso, Fabio S...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7936616/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
1-15